The Cancer Council WA has launched the “It is time to act” campaign to address a stark disparity in lung cancer outcomes between Western Australia’s metropolitan and regional populations. Data from the WA Cancer Registry shows that between 2018 and 2022, the five-year survival rate for lung cancer was 35 per cent in metropolitan Perth, … Read more
A new international study reveals that global tobacco control campaigns have failed to bridge a critical knowledge gap over two decades, leaving millions of smokers unaware that tobacco causes heart attacks, strokes, and cardiovascular disease. According to research published in BMJ Open by teams at the University of Waterloo and the U.S. Centers for Disease … Read more
Lung cancer is no longer exclusively a smoker’s disease, as rising global incidence rates and clinical observations challenge long-held medical assumptions. Worldwide, approximately 2.5 million people were diagnosed with lung cancer annually in 2022, reflecting an age-adjusted standardized ratio of roughly 24 cases per 100,000 people. While male incidence rates have declined across most countries … Read more
Lung cancer diagnoses are rising among non-smokers, driven by severe air pollution, indoor biomass smoke, second-hand tobacco exposure, and specific genetic mutations according to medical experts. Oncologists report that this shift challenges the long-held perception that tobacco is the sole cause of the disease, leaving many patients facing delayed diagnoses because persistent respiratory symptoms are … Read more
< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more
A new dendritic cell vaccine platform known as PROTEXI redirects pre-existing antiviral immune memories from SARS-CoV-2 infections or vaccinations to help the immune system recognize and eliminate therapy-resistant tumors, according to a study published in Nature Communications by researchers from Celloram Inc, University Hospitals, and Case Western Reserve University. Redirecting Pandemic Immunity Against Solid Tumors … Read more
Inherited genetics directly shape how our DNA interacts with acquired mutations to drive tumor evolution, according to research published in Nature. Scientists at the University of Cambridge and the University of Edinburgh found that an individual’s genetic background dictates both cancer risk and the specific evolutionary paths tumors take, offering new direction for precision medicine … Read more
Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more
Robotic-assisted bronchoscopy (RAB) achieves a 96.7% diagnostic yield for peripheral lung nodules when integrated with real-time imaging, according to the MATCH 2 study published in Respiratory Medicine. The research confirms that combining digital tomosynthesis (DT) and augmented fluoroscopy (AF) provides tool-in-lesion accuracy comparable to cone-beam computed tomography (CBCT), offering a precise method for early lung … Read more
Chloe Houghton, a 32-year-old non-smoker from Northamptonshire, was diagnosed with terminal stage 4 Small Cell lung cancer in 2026 after a chest lump initially dismissed by doctors as a benign cyst was found to be a metastatic tumor. According to reports, the diagnosis followed months of misdiagnosed symptoms, including extreme fatigue and weight loss, highlighting … Read more